C.R. Bard announced last week that it raised the quarterly dividend for its shareholders 6% to 18 cents a share. BCR stock will also be part of a new buyback program worth about $500 million. The medical device maker made its next dividend payable Aug. 6 to shareholders of record as of July 26.
C.R. Bard has a respectable dividend yield of about 0.9%, and the stock is up about 4% year to date, so this isn't exactly a homerun. But dividend stock investors should take notice of the recent increase to C.R. Bard's yield.
At the time of publication, Reeves had no positions in stocks mentioned.